Extraordinary diseases require extraordinary solutions
- PMID: 32331807
- PMCID: PMC7167540
- DOI: 10.1016/j.vaccine.2020.04.039
Extraordinary diseases require extraordinary solutions
References
-
- Henao-Restrepo A.M., Camacho A., Longini I.M., Watson C.H., Edmunds W.J., Egger M. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!) Lancet. 2017;389(10068):505–518. doi: 10.1016/s0140-6736(16)32621-6. - DOI - PMC - PubMed
-
- Eyal N, Lipsitch M, Smith PG. Human challenge studies to accelerate coronavirus vaccine licensure. Preprint at DASH http://nrs.harvard.edu/urn-3:HUL.InstRepos:42639016 (March 24, 2020). - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical